4baseCare Raises $4.33 Million in Series B Funding
Bengaluru-based 4baseCare, a company focused on personalizing cancer care through genomic diversity and artificial intelligence, has successfully raised $4.33 million (₹38 crore) in a Series B funding round. This latest investment was led by growX Ventures.
Company Background
Founded by Hitesh Goswami and Kshitij Rishi, who serve as CEO and COO respectively, 4baseCare is dedicated to transforming cancer treatment by leveraging genomic data and AI. The company aims to tailor cancer therapies for individual patients, enhancing outcomes and providing more precise care.
Lead Investor
The Series B round was led by growX Ventures, a venture capital firm known for investing in innovative technology-driven startups. The participation of growX Ventures underscores the growing interest in health tech solutions that integrate advanced technologies like genomics and AI.
Strategic Use of Funds
While specific plans for the funding were not disclosed, companies in this sector typically use such capital injections to enhance their technology platforms, expand their research capabilities, and potentially increase their market reach. Given 4baseCare's focus, it is likely that the funds will be deployed to further develop their AI and genomic tools, aiming to improve personalized cancer treatment options.
Founders' Vision
Hitesh Goswami and Kshitij Rishi have been pivotal in steering 4baseCare towards its mission of revolutionizing cancer care. "Our goal is to make personalized cancer care accessible to every patient, everywhere," said Goswami. This funding round marks a significant step in realizing that vision.
Conclusion
With the new capital from growX Ventures, 4baseCare is well-positioned to enhance its offerings in the personalized cancer care space. As the company continues to innovate, it holds the promise of making significant strides in the way cancer is treated globally, making treatments more effective and tailored to individual needs.